Why is Valiant Laborato falling/rising?

As of 07-Jul, Valiant Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 115.85, which represents a decrease of Rs 1.85 or 1.57%. Today's price summary indicates that the stock has underperformed its sector by 1.49% and has fallen after three consecutive days of gains, touching an intraday low of Rs 115.25. Despite trading above its moving averages, the stock's long-term fundamentals are weak, with a negative EBITDA and a poor return on equity of 0%. While there have been positive results in the last quarter, including a higher profit after tax and net sales, the overall trend shows a concerning annual decline in net sales and operating profit over the past five years.
In the broader market context, Valiant Laboratories has shown a short-term return of +1.98% over the past week, outperforming the Sensex, which has seen a slight decline of 0.20%. However, the stock's year-to-date performance of +4.60% lags behind the Sensex's +6.79%. The increasing participation from institutional investors, who have raised their stake by 0.64%, suggests some confidence in the company's potential, but the consistent underperformance against benchmarks over the last three years, coupled with a significant drop in profits, raises concerns about its long-term viability.